Opens in a new tab

Gallstones: Symptoms, Causes, Blood Tests and Treatment

Table of Content

Friendly doctor pointing to a simple liver and gallbladder diagram for a smiling older man in a bright clinic, with an ultrasound probe, blood test tubes, a lab report and a bowl of fruit and vegetables on the desk

⚕️ This article is for informational purposes only and does not replace medical advice. Always consult your doctor to interpret your results.

Gallstones are hard, pebble-like deposits that form inside the gallbladder, a small pouch under the liver that stores bile. Most are made of hardened cholesterol, some of bilirubin. They affect 10 to 15% of people in the United States, almost 25 million adults, according to the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), yet most never cause symptoms.

When a stone blocks the outlet of the gallbladder or a bile duct, it causes a "gallbladder attack": steady, often intense pain in the upper right or middle of the belly, frequently after a heavy meal or at night, lasting from 30 minutes to several hours. Fever, chills, yellow skin or eyes, dark urine or pale stools are warning signs of a complication such as cholecystitis, cholangitis or gallstone pancreatitis. An ultrasound finds most gallstones, blood tests show whether the liver, bile ducts or pancreas are involved, and surgery to remove the gallbladder is the usual cure for stones that cause symptoms.

Key takeaways

  • About 8 in 10 people with gallstones have no symptoms, and silent stones usually need no treatment.
  • Typical pain sits under the right ribs or in the upper middle belly and can spread to the right shoulder or between the shoulder blades.
  • Liver function tests (bilirubin, ALP, GGT, ALT, AST), lipase, a white blood cell count and CRP help detect complications; a bilirubin above 4 mg/dL (68 µmol/L) raises concern for a stone in the bile duct.
  • Gallbladder removal (cholecystectomy), usually by keyhole surgery, is the standard treatment for symptomatic stones; most people go home the same day.
  • Rapid weight loss raises the risk, including weight loss from GLP-1 drugs such as semaglutide; recent meta-analyses find about 25 to 40% more gallbladder events with these drugs.

What are gallstones and what is gallbladder disease?

The liver makes bile, a fluid that helps digest fat. Between meals, bile is stored and concentrated in the gallbladder. After you eat, the gallbladder squeezes bile through the cystic duct and the common bile duct into the small intestine. Gallstones form when bile contains too much cholesterol or bilirubin, or not enough bile salts, or when the gallbladder does not empty completely or often enough, the NIDDK explains. Doctors call the condition cholelithiasis.

Stones range from a grain of sand to a golf ball. There are two main types:

  • Cholesterol stones, usually yellow-green, the most common type. MedlinePlus notes that they are not related to the cholesterol level in your blood.
  • Pigment stones, dark and made of bilirubin, more frequent when red blood cells break down too fast, as in sickle cell disease.

"Gallbladder disease" is an umbrella term. Cleveland Clinic lists gallstones as the most common cause of gallbladder problems. The main conditions linked to stones are:

  • Biliary colic: pain from a stone that temporarily blocks the gallbladder outlet, without lasting inflammation.
  • Acute cholecystitis: inflammation of the gallbladder, most often because a stone stays stuck in the cystic duct.
  • Choledocholithiasis: a stone that has moved into the common bile duct and can block bile flow from the liver.
  • Acute cholangitis: infection of a blocked bile duct, a medical emergency.
  • Gallstone (biliary) pancreatitis: inflammation of the pancreas when a stone blocks the shared outlet of the bile and pancreatic ducts. Our guide to pancreatitis symptoms and when to worry covers this condition in depth.

Rarer problems include gangrene or perforation, described in our article on gallbladder rupture symptoms and treatment, gallbladder polyps and, rarely, gallbladder cancer.

How common are gallstones?

A 2024 meta-analysis of 115 studies and more than 32 million people found that 6.1% of the world population has gallstones. Rates were higher in women than in men (7.6% versus 5.4%), in South America (11.2%) and with advancing age, and new cases may be increasing. In the United States, the NIDDK estimates that nearly 1 million people are diagnosed each year and about a quarter of them need treatment, usually surgery.

Causes and risk factors

Medical students learn the "4 F" or "5 F" rule: female, forty, fertile, fat (and fair). Cleveland Clinic points out that the mnemonic is controversial because it encourages stereotypes, but it does reflect real risk factors:

  • Sex and hormones: women are two to three times more likely than men to form stones. Estrogen raises cholesterol in bile and progesterone slows gallbladder emptying, so pregnancy, birth control pills and hormone therapy add risk.
  • Age: risk rises after 40, according to MedlinePlus.
  • Body weight: obesity, especially in women, and metabolic syndrome, diabetes or insulin resistance. Our article on fatty liver disease explains how the same metabolic factors affect the liver.
  • Rapid weight loss: very low-calorie diets, weight-loss surgery and, more recently, GLP-1 medicines.
  • Family history and ancestry: American Indians have the highest rate in the United States, followed by Mexican Americans, the NIDDK says.
  • Blood fats: high triglycerides and low HDL cholesterol.
  • Other conditions: cirrhosis, Crohn's disease, hemolytic anemias such as sickle cell disease, long-term intravenous feeding and organ transplants.

Gallstone symptoms: what a gallbladder attack feels like

Most gallstones are "silent". When symptoms occur, they usually follow a pattern:

  • Pain in the upper right belly, under the ribs, or in the upper middle belly. MedlinePlus says it lasts at least 30 minutes and may be steady or cramping, sharp or dull.
  • Pain that spreads to the back, below the right shoulder blade, between the shoulder blades or to the right shoulder.
  • Attacks that often start after a heavy or fatty meal, in the evening or at night, and can wake you from sleep.
  • Nausea and vomiting. If you keep vomiting yellow-green fluid, see our guide to vomiting bile and its warning signs.

An attack usually ends when the stone moves; after one attack, more are likely. Cleveland Clinic warns that pain in unusual places can be mistaken for heartburn, indigestion or even a heart attack, which is why chest pain always deserves urgent care.

Signs of a complication

The NIDDK advises immediate care if, during or after an attack, you have:

  • abdominal pain lasting several hours;
  • nausea and vomiting;
  • fever, even low-grade, or chills;
  • yellowing of the skin or the whites of the eyes (jaundice);
  • tea-colored urine and light-colored or clay-colored stools.

How gallstones are diagnosed

During the exam, pain when the doctor presses under the right ribs while you breathe in (Murphy's sign) suggests cholecystitis, although the 2020 World Society of Emergency Surgery (WSES) guidelines note that no single sign or test is enough on its own: fever, right upper belly pain, Murphy's sign, a raised C-reactive protein (CRP), a raised white blood cell count and imaging signs are interpreted together.

Blood tests

Blood tests mainly show signs of infection or inflammation of the bile ducts, gallbladder, pancreas or liver (NIDDK):

Imaging tests

  • Abdominal ultrasound: the NIDDK calls it the best imaging test for finding gallstones, and the WSES recommends it as the first test because it is cheap, widely available, painless and accurate. It can also show signs of gallbladder inflammation and the width of the bile duct.
  • HIDA scan (cholescintigraphy): a small dose of a radioactive tracer follows bile through the liver and gallbladder. The WSES says it has the highest sensitivity and specificity for acute cholecystitis, but it takes more time and resources.
  • MRCP (magnetic resonance cholangiopancreatography): an MRI of the bile and pancreatic ducts, without X-rays, used to look for stones in the bile duct.
  • Endoscopic ultrasound (EUS): an ultrasound probe on a thin tube passed through the mouth; the WSES lists it with MRCP as a second-level test for duct stones.
  • CT scan: useful for complications, but it may miss gallstones; WSES rates its accuracy for cholecystitis as poor.
  • ERCP (endoscopic retrograde cholangiopancreatography): an endoscope and X-rays used mainly to remove a stone stuck in the bile duct. The American Society for Gastrointestinal Endoscopy notes adverse events in 6 to 15% of ERCPs, so doctors prefer to confirm the stone first with MRCP or EUS unless the risk is high.

Gallbladder blood test results: reference values and warning thresholds

This table gives common adult reference ranges from MedlinePlus and thresholds used in gallstone guidelines. Always compare with the range on your own report.

TestUsual adult range (US unit / SI unit)What can point to a gallstone complication
Total bilirubin0.1 to 1.2 mg/dL / 1.71 to 20.5 µmol/LAbove 4 mg/dL (68 µmol/L), or 1.8 to 4 mg/dL (31 to 68 µmol/L) with a widened bile duct: moderate risk of a duct stone (WSES 2020)
Direct (conjugated) bilirubinLess than 0.3 mg/dL / less than 5.1 µmol/LRises when bile cannot drain (obstruction)
Alkaline phosphatase (ALP)40 to 129 IU/L / 0.68 to 2.19 µkat/LRaised with biliary obstruction; normally higher in pregnancy and in growing children
GGT5 to 40 U/L / 0.08 to 0.67 µkat/LRaised with cholestasis; confirms that a high ALP comes from the liver
ALT4 to 36 U/L / 0.07 to 0.60 µkat/LAbnormal values support, but do not prove, a duct stone
AST8 to 33 U/L / 0.13 to 0.55 µkat/LSame pattern as ALT
Lipase0 to 160 U/L / 0 to 2.67 µkat/LMore than 3 times the upper limit of normal, with typical pain: acute pancreatitis
Amylase40 to 140 U/L / 0.67 to 2.34 µkat/LSame 3-times rule; less specific than lipase
White blood cells4,500 to 11,000 cells/µL / 4.5 to 11.0 × 10⁹/LHigh count with fever: cholecystitis or cholangitis
CRPMost healthy adults below 0.3 mg/dL / below 3 mg/LRaised with gallbladder inflammation (one of the diagnostic clues)

How to read your results

  • High white cells and CRP, fever and a tender gallbladder: suggests acute cholecystitis. Liver tests may be normal or mildly raised.
  • High bilirubin, ALP and GGT, often with abnormal ALT and AST: suggests a stone in the common bile duct. The WSES guidelines warn that abnormal liver tests alone are not enough to prove a duct stone, so imaging follows.
  • The same obstructive pattern plus fever, chills and jaundice: possible cholangitis, which needs emergency care.
  • Lipase more than three times the upper limit with upper belly pain: acute pancreatitis; gallstones are the most common cause in the United States, according to MedlinePlus.

A single mildly raised value, such as an ALT slightly above the range, has many other explanations, such as fatty liver or hepatitis. Results always need to be read with your symptoms and imaging.

Treatment for gallstones

Silent gallstones

Stones found by chance on an ultrasound and causing no symptoms usually need no treatment, according to the NIDDK. Your doctor may discuss surgery in special situations, for example before weight-loss surgery.

Treating a gallbladder attack

A 2024 review in Seminars in Liver Disease says biliary colic is treated with nonsteroidal anti-inflammatory drugs (NSAIDs) and antispasmodic medicines, with opioids reserved for severe pain. Repeated attacks are a reason to plan surgery, because the risk of recurrence and complications increases over time.

Gallbladder removal (cholecystectomy)

Removing the gallbladder is the usual treatment for symptomatic stones. Nearly all surgeons use laparoscopic (keyhole) surgery: many people go home the same day and return to normal activity in about a week. Open surgery, used when the gallbladder is badly inflamed or scarred, means a hospital stay of up to a week and about a month of recovery, the NIDDK says. Complications are rare; the most important is injury to the bile duct.

You can live normally without a gallbladder: bile simply flows directly from the liver into the intestine. A small number of people have softer or more frequent stools afterward, usually temporarily. MedlinePlus adds that nearly all people who have their gallbladder removed do not see their symptoms come back.

Treatment of complications

  • Acute cholecystitis: hospital care with fluids, pain relief and antibiotics, then early laparoscopic cholecystectomy. The WSES recommends surgery as soon as possible, within 7 days of admission and within 10 days of the start of symptoms, even in older adults. For people too ill for surgery, a drainage tube can be placed in the gallbladder.
  • Bile duct stones: removed with ERCP, before, during or after cholecystectomy depending on the hospital.
  • Cholangitis: antibiotics right away and drainage of the blocked duct, usually by ERCP. The Tokyo Guidelines 2018 found lower 30-day mortality when moderate (grade II) cholangitis was drained early.
  • Gallstone pancreatitis: supportive care, then removal of the gallbladder during the same hospital stay when the attack is mild, to prevent a new episode.

Medicines that dissolve stones

Ursodiol (ursodeoxycholic acid, ChEMBL CHEMBL1551, first approved in 1987) is a bile acid that can slowly dissolve small cholesterol stones. It may take months to two years or more, works in only about half of people according to Cleveland Clinic, and stones often return after it is stopped. It is mostly used for people who cannot or do not want to have surgery, or to prevent stones during rapid weight loss.

Gallstone diet and prevention

No diet dissolves existing stones, and MedlinePlus notes that gallstones usually cannot be fully prevented. The NIDDK recommends habits that lower the risk and may reduce attacks:

  • more high-fiber foods: fruits, vegetables, beans, peas and whole grains such as brown rice, oats and whole wheat bread;
  • fewer refined carbohydrates and less sugar;
  • healthy fats such as fish oil and olive oil, which help the gallbladder contract and empty regularly;
  • fewer fats from desserts and fried foods;
  • regular physical activity and a healthy weight, reached gradually rather than through crash diets.

Because attacks often follow heavy or fatty meals, a low-fat diet is part of the non-surgical care of cholecystitis described by MedlinePlus. Before weight-loss surgery or a very low-calorie diet, ask about preventive ursodiol.

Gallstones in pregnancy, women and older adults

Pregnancy hormones slow the gallbladder and increase cholesterol in bile, and gallbladder disease is the leading non-obstetric reason for hospitalization during pregnancy, a 2025 study in Langenbeck's Archives of Surgery reports. Surgical societies (SAGES) and obstetricians (ACOG) consider laparoscopic cholecystectomy safe in all trimesters. In that 10-year series of 228 pregnant patients, most were treated without surgery, but 77% had recurrent symptoms.

Gallstone symptoms are the same in women and men, but women develop stones more often and earlier, roughly between 20 and 50 years of age, whereas men are more often affected after 60, according to Cleveland Clinic.

In older adults, the WSES guidelines support laparoscopic surgery for acute cholecystitis even after age 80, and a 2025 analysis of the international SPRiMACC study found that frailty and overall physical condition, not age alone, predicted complications after early surgery.

When to see a doctor

Book a visit for repeated episodes of upper belly pain after meals, even if they pass on their own.

Call 911 or go to the emergency room if you have:

  • severe belly pain that does not ease after a few hours;
  • fever or chills with belly pain;
  • yellow skin or eyes, very dark urine or pale stools;
  • repeated vomiting;
  • chest pain, shortness of breath or sweating, which can be a heart attack rather than a gallbladder attack;
  • a fast heartbeat, feeling faint or a swollen belly with abdominal pain, which can signal a serious complication.

Latest scientific advances in gallstones and gallbladder disease

GLP-1 weight-loss medicines and the gallbladder

A 2022 JAMA Internal Medicine meta-analysis of 76 trials (103,371 patients) found that GLP-1 receptor agonists raised the risk of gallbladder or biliary disease by 37%, with a stronger effect in weight-loss trials (relative risk 2.29), at higher doses and with longer use. Newer analyses confirm the signal: a 2025 meta-analysis in the Journal of the American College of Cardiology (21 trials, 99,599 patients) found 26% more gallbladder disorders. In people with obesity but no diabetes, a 2025 meta-analysis of 13 trials found that semaglutide (ChEMBL CHEMBL2108724) increased gallstones about 2.6-fold, while tirzepatide showed no significant biliary risk. A 2026 umbrella review in JAMA Network Open estimated the overall odds at 1.34 but judged the evidence exploratory. For you: do not stop treatment on your own, but report right-sided belly pain, fever or jaundice promptly. Our article on what happens when you stop GLP-1 drugs covers the other side of the decision.

Surgery or watchful waiting for uncomplicated stones?

The UK C-GALL trial, published in full in 2024, randomized 434 adults with uncomplicated symptomatic gallstones to cholecystectomy or observation. At 18 months, general bodily pain scores were the same in both groups, and observation was cheaper. However, gallstone-specific quality of life favored surgery at 24 months, and 29.5% of the observation group ended up having surgery anyway. For you: if attacks are rare and mild, waiting can be a reasonable choice to discuss; if they keep coming back, surgery gives better gallstone-related relief.

Preventing stones after weight-loss surgery

In the Dutch UPGRADE trial (985 patients), 900 mg of ursodiol daily for 6 months did not significantly reduce symptomatic gallstone disease overall (6.5% versus 9.7%), but it did in patients without stones before gastric bypass. A 2026 meta-analysis of 10 randomized trials (3,575 participants) in BMC Surgery found that preventive ursodiol cut new gallstone formation by 67% at 12 to 24 months and symptomatic stones by 70%, with doses of 500 to 600 mg a day for 6 to 12 months effective; gallbladder removal rates did not differ.

Timing of surgery after gallstone pancreatitis

Gallstones cause about half of all cases of acute pancreatitis. A 2024 JAMA Surgery review states that people with mild gallstone pancreatitis should have their gallbladder removed during the same admission, ideally early, while surgery should be delayed in severe disease. A 2025 randomized trial of 120 patients in HPB found that surgery within 72 hours shortened the hospital stay (5 versus 7 days) without more complications. The optimal timing after moderately severe or severe pancreatitis is still being tested in the CHISPA trial (NCT06113419), which compares surgery during the hospital stay with surgery about 30 days later.

Making emergency gallbladder surgery safer

Inflammation can blur the anatomy and increase the risk of bile duct injury during emergency surgery. Indocyanine green (ICG) fluorescence, a dye that makes bile ducts glow under near-infrared light, is being tested in a 296-patient multicenter trial in acute cholecystitis (NCT07481760, start planned for 2027). Meanwhile, a phase 4 trial at 13 sites (NCT07005752) is comparing a new oral medicine with ursodiol in 484 people with cholesterol gallstones.

Which tests can help?

If you have symptoms that could come from gallstones, ask your doctor about:

  • an abdominal ultrasound, the first-line test;
  • a liver panel: total and direct bilirubin, ALP, GGT, ALT and AST;
  • lipase (and sometimes amylase) if the pain is in the upper middle belly or spreads to the back;
  • a complete blood count and CRP if you have fever or persistent pain;
  • MRCP or endoscopic ultrasound if blood tests or the ultrasound suggest a stone in the bile duct;
  • a HIDA scan if cholecystitis is suspected but the ultrasound is unclear;
  • a lipid panel and diabetes tests, since high triglycerides, low HDL and diabetes are linked to gallstones.

Glossary

  • Bile: a yellow-green digestive fluid made by the liver and stored in the gallbladder; it helps digest fat.
  • Biliary colic: pain caused by a gallstone temporarily blocking the gallbladder outlet.
  • Cholecystitis: inflammation of the gallbladder, usually due to a stone stuck in the cystic duct.
  • Choledocholithiasis: a gallstone in the common bile duct.
  • Cholangitis: infection of a blocked bile duct.
  • Cholecystectomy: surgery to remove the gallbladder.
  • ERCP: an endoscopic procedure that uses X-rays to see and clear the bile ducts.
  • Ursodiol: a bile acid medicine that can dissolve small cholesterol stones and prevent new ones.

Frequently asked questions

What are common signs of gallstones?

Most people have none. When stones cause symptoms, the typical sign is steady pain in the upper right or upper middle belly lasting from 30 minutes to a few hours, often after a heavy meal or at night, sometimes spreading to the right shoulder or back, with nausea or vomiting. Fever, jaundice, dark urine or pale stools signal a complication.

What is the recommended diet for people with gallstones?

The NIDDK recommends more fiber (fruits, vegetables, beans, whole grains), fewer refined carbohydrates and sugars, healthy fats such as olive oil and fish oil, fewer fried foods and desserts, and gradual weight loss. Attacks often follow heavy meals, but diet alone does not dissolve stones.

What is a gallbladder?

It is a small pouch under the liver, on the right side of the belly. It stores and concentrates bile between meals and squeezes it into the intestine after you eat. It is useful but not essential.

Are gallstones curable?

Yes. Removing the gallbladder cures gallstone disease in nearly everyone, and stones cannot form again in the gallbladder once it is gone. Medicines like ursodiol can dissolve some small cholesterol stones, but they work slowly, not in everyone, and stones often come back.

Are gallstones dangerous, and can they kill you?

Silent stones are usually harmless, but the NIDDK warns that untreated blockages of the bile ducts or pancreatic duct can be fatal, through severe cholangitis, gangrene or perforation of the gallbladder, or severe pancreatitis. Prompt treatment makes these outcomes rare.

Are gallstone symptoms different in women?

The symptoms are the same, but women are two to three times more likely to have gallstones, often earlier in life, and pregnancy, birth control pills and hormone therapy raise the risk. Gallbladder pain in pregnancy should always be checked.

Sources

  • Wang X et al. — Global Epidemiology of Gallstones in the 21st Century: A Systematic Review and Meta-Analysis — Clin Gastroenterol Hepatol, 2024 — doi.org
  • Lammert F, Wittenburg H — Gallstones: Prevention, Diagnosis, and Treatment — Semin Liver Dis, 2024 — doi.org
  • Pisano M et al. — 2020 World Society of Emergency Surgery updated guidelines for the diagnosis and treatment of acute calculus cholecystitis — World J Emerg Surg, 2020 — doi.org
  • Yokoe M et al. — Tokyo Guidelines 2018: diagnostic criteria and severity grading of acute cholecystitis — J Hepatobiliary Pancreat Sci, 2018 — doi.org
  • Kiriyama S et al. — Tokyo Guidelines 2018: diagnostic criteria and severity grading of acute cholangitis — J Hepatobiliary Pancreat Sci, 2018 — doi.org
  • ASGE Standards of Practice Committee, Buxbaum JL et al. — ASGE guideline on the role of endoscopy in the evaluation and management of choledocholithiasis — Gastrointest Endosc, 2019 — doi.org
  • Oppenlander KE, Chadwick C, Carman K — Acute Pancreatitis: Rapid Evidence Review — Am Fam Physician, 2022 — pubmed.ncbi.nlm.nih.gov
  • McDermott J et al. — Management of Gallstone Pancreatitis: A Review — JAMA Surg, 2024 — doi.org
  • Zhou W et al. — Randomized controlled trial of early versus late cholecystectomy in patients with mild acute pancreatitis — HPB (Oxford), 2025 — doi.org
  • Fugazzola P et al. — Age is not so important for risk stratification in early cholecystectomy for acute calculous cholecystitis: post-hoc analysis of the SPRiMACC study — Medicina (Kaunas), 2025 — doi.org
  • Innes K et al. — Laparoscopic cholecystectomy versus conservative management for adults with uncomplicated symptomatic gallstones: the C-GALL RCT — Health Technol Assess, 2024 — doi.org
  • He L et al. — Association of GLP-1 receptor agonist use with risk of gallbladder and biliary diseases: a systematic review and meta-analysis — JAMA Intern Med, 2022 — doi.org
  • Galli M et al. — Cardiovascular effects and tolerability of GLP-1 receptor agonists: a systematic review and meta-analysis of 99,599 patients — J Am Coll Cardiol, 2025 — doi.org
  • Safwan M et al. — Gastrointestinal safety of semaglutide and tirzepatide vs. placebo in obese individuals without diabetes: a systematic review and meta-analysis — Ann Saudi Med, 2025 — doi.org
  • Yang K et al. — GLP-1 receptor agonists and noncardiometabolic outcomes: an umbrella review of meta-analyses — JAMA Netw Open, 2026 — doi.org
  • Haal S et al. — Ursodeoxycholic acid for the prevention of symptomatic gallstone disease after bariatric surgery (UPGRADE) — Lancet Gastroenterol Hepatol, 2021 — doi.org
  • Alrubaiaan A et al. — Efficacy of prophylactic ursodeoxycholic acid in preventing gallstone formation after metabolic bariatric surgery: updated meta-analysis of RCTs — BMC Surg, 2026 — doi.org
  • Hassanesfahani M et al. — Between guidelines and reality; the complex decision-making of acute cholecystitis in pregnancy — Langenbecks Arch Surg, 2025 — doi.org
  • ClinicalTrials.gov — Timing of CHolecystectomy In Severe PAncreatitis (CHISPA), NCT06113419 — clinicaltrials.gov
  • ClinicalTrials.gov — Indocyanine green fluorescence to reduce biliary complications in emergency cholecystectomy (ICG-ACBC), NCT07481760 — clinicaltrials.gov
  • ClinicalTrials.gov — CnU capsule versus ursodiol in cholesterol gallstones, NCT07005752 — clinicaltrials.gov
  • NIDDK — Definition and Facts for Gallstones — National Institutes of Health — niddk.nih.gov
  • NIDDK — Symptoms and Causes of Gallstones — National Institutes of Health — niddk.nih.gov
  • NIDDK — Diagnosis of Gallstones — National Institutes of Health — niddk.nih.gov
  • NIDDK — Treatment for Gallstones — National Institutes of Health — niddk.nih.gov
  • NIDDK — Eating, Diet, and Nutrition for Gallstones — National Institutes of Health — niddk.nih.gov
  • MedlinePlus — Gallstones — National Library of Medicine, 2025 — medlineplus.gov
  • MedlinePlus — Acute cholecystitis — National Library of Medicine, 2025 — medlineplus.gov
  • MedlinePlus — Acute pancreatitis — National Library of Medicine, 2025 — medlineplus.gov
  • MedlinePlus — Bilirubin blood test; ALP blood test; ALT and AST blood tests; GGT blood test; Lipase test; Amylase blood test; WBC count; C-reactive protein — National Library of Medicine, 2025 — medlineplus.gov
  • Cleveland Clinic — Gallstones — clevelandclinic.org
  • Cleveland Clinic — Gallbladder Disease — clevelandclinic.org
  • EMBL-EBI — ChEMBL: ursodiol (CHEMBL1551), semaglutide (CHEMBL2108724) — ChEMBL — ebi.ac.uk

Further reading

Understand your lab results with AI DiagMe

Gallstone complications show up in bilirubin, ALP, GGT, ALT, AST, lipase, white blood cells and CRP. AI DiagMe reads your lab report in minutes, explains each value in plain language, shows whether the pattern looks like bile duct obstruction, inflammation or a pancreas problem, and suggests questions to ask your doctor. Upload your lab results to AI DiagMe for a clear, personal report.

Editorial team

  • AI DiagMe

    Author

    The AI DiagMe team brings together physicians, clinical specialists, and medical editors. Our articles are written by health communication professionals and then reviewed and validated by the physicians of our scientific committee, composed of practicing hospital physicians in specialties such as hematology, endocrinology, and general medicine. Julien Priour, who leads the editorial mission, holds an MBA from HEC Paris and was trained in scientific writing and publishing by the French National Research Institute for Sustainable Development (IRD, FUN-MOOC, 2026). Each piece of content is based on current clinical guidelines and peer-reviewed medical publications.

    Email Website
  • Julien Priour

    Edited by

    Co-founder and CEO of AI DiagMe · Senior medical editor · HEC Paris graduate

    Julien Priour is a senior medical editor at AI DiagMe, where he oversees the editorial line and the fact-checking process. A graduate of HEC Paris, he has 3 years of experience in health publishing and was trained in scientific writing and publishing by the French National Research Institute for Sustainable Development (IRD, FUN-MOOC, 2026). He makes sure that every article follows current medical guidelines and is reviewed and validated by a physician from the scientific and ethics committee. He sets the sourcing standards (HAS, Ameli, INSERM…) and the review standards applied across the entire site.

    Email LinkedIn
  • Dr. Claude Tchonko

    Medically reviewed by

    Dr. Claude Tchonko is a hematologist, in practice since 2013, currently working at Clinique Mas de Rochet (Castelnau-le-Lez, France). With an international background, he specializes in the management of hematologic malignancies (leukemias, lymphomas, myelomas), with particular expertise in autologous stem cell transplantation, CAR-T cell therapy and the optimization of care pathways in onco-hematology.

    Author of a reference work, “Lymphoid Hematologic Malignancies in Mali”, he combines clinical practice with active involvement in projects developing technology solutions for healthcare.

    He holds a State Doctorate in Medicine (Faculty of Medicine of Bamako, 2006) and completed his training with a Certificate of Specialized Studies in Bioclinical Hematology (Abidjan-Cocody, 2010) and several university diplomas: a DFMS in Hematology and an inter-university diploma (DIU) in Onco-Hematological Cytogenetics (Grenoble), as well as a university diploma (DU) in major sickle cell disease (UPEC).

    Dr. Claude Tchonko LinkedIn

Related Posts

Coming Soon